Avidity biosciences to participate in upcoming investor conferences

San diego , feb. 25, 2025 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced that avidity management will participate in a fireside chat during each of the following investor conferences: td cowen 45th annual health care conference on tuesday, march 4, 2025, at 3:10 p.m. et leerink partners global healthcare conference on tuesday, march 11, 2025, at 1:00 p.m.
RNA Ratings Summary
RNA Quant Ranking